ARTICLE | Clinical News
Zorvolex lower dose submicron diclofenac regulatory update
September 8, 2014 7:00 AM UTC
FDA approved an sNDA from Iroko for Zorvolex to treat osteoarthritis pain in adults. The product is approved in the U.S. to treat mild to moderate acute pain in adults. Iroko launched Zorvolex in January. ...